Science AI Journal
Medicine · Research topic

Open research questions in Chemotherapy-induced organ toxicity mitigation

80 gap statements mined from Chemotherapy-induced organ toxicity mitigation papers in our 4.5M-paper local library, which holds 473 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Chemotherapy-induced organ toxicity mitigation? See the ranked Medicine journals.

What the literature leaves open

  • There is a need for effective prevention strategies to mitigate Cisplatin-induced AKI. The underlying mechanisms of Cisplatin-induced nephrotoxicity are not fully understood.

    Secukinumab Mitigates Cisplatin-Induced Nephrotoxicity and Enhances Cisplatin Cytotoxicity in MCF-7 Cells via IL-17A/NF-κB Axis Modulation · 2026 · DOI

  • Although DPG could be considered as a renoprotective drug, further research incorporating in vitro experiments is warranted to further clarify the direct molecular mechanisms involved in CIS nephrotoxicity, validate its role as a possible mitophagy regulator and establish its beneficial effects in diabetic patients.

    Dapagliflozin attenuates cisplatin-induced nephrotoxicity in rats through modulation of ROS/NF-κB, BCL2/Bax and PINK1/Parkin signaling pathways · 2026 · DOI

  • Current clinical evidence Clinical studies of Astragalus in kidney disorders provide proof-of-concept for the therapeutic potential of APS, although direct evidence in AKI remains limited (Liu M. et al., 2024).

    Function of molecular-weight-optimized Astragalus polysaccharides in cisplatin-caused acute kidney injury: mechanisms centered on gut microbiota regulation and precise treatment approaches · 2026 · DOI

  • The study is limited to in vitro experiments. The need for additional in vivo studies to determine the therapeutic usefulness and safety of GLE is acknowledged.

    Anti-nephrolithiatic activity of Garcinia lanceifolia Roxb: An in vitro Study · 2026 · DOI

  • Finally, although SIRT1/PGC-1α signaling was implicated, downstream targets and alternative mechanisms, including inflammatory signaling, mitophagy, ferroptosis, and NAD+ metabolism, remain to be investigated.

    Sophocarpine Alleviates Renal Ischemia–Reperfusion Injury by Mitigating Oxidative Stress and Mitochondrial Dysfunction via the SIRT1/PGC-1α Axis · 2026 · DOI

  • The underlying mechanisms of gut microbiota metabolites against renal fibrosis remain unclear. Current therapeutic approaches for renal fibrosis have failed to yield satisfactory results.

    Unveiling the therapeutic potential of gut microbiota metabolites for the treatment of renal fibrosis based on network pharmacology study · 2026 · DOI

  • The study is limited by the use of an acute MTX-induced lung toxicity model, which may not fully mimic chronic human pulmonary fibrosis.

    Modulation of NF-κB and cytokine signaling by Cordia dichotoma and Cordia myxa attenuates methotrexate-induced pulmonary inflammation and oxidative injury in rats · 2026 · DOI

  • Pyraclostrobin (PY) is a commonly applied strobilurin‐class fungicide that is frequently identified as a residue in food products, yet its nephrotoxic mechanisms remain unclear.

    Pyraclostrobin Exposure Triggers Renal Injury by Activating Wnt/β‐Catenin Signaling Pathway‐Mediated Renal Fibrosis in Mice · 2026 · DOI

  • Doxorubicin-induced kidney injury is a major concern in chemotherapy. The toxic metabolite of doxorubicin generates free radicals that attack cell membranes and disrupt their functions. There is a lack of studies on the nephroprotective effects of natural products.

    Nephroprotective effect of seed extract and fractions of Telfairia occidentalis on doxorubicin-induced kidney injury in rats · 2026 · DOI

  • There is a need to find natural products that can mitigate the toxic effects of doxorubicin. There is a lack of studies on the nephroprotective effects of Telfairia occidentalis seed extract and fractions.

    Nephroprotective effect of seed extract and fractions of Telfairia occidentalis on doxorubicin-induced kidney injury in rats · 2026 · DOI

  • There is a need to investigate the protective effects of medicinal plants, such as Vitellaria paradoxa, against benzene-induced toxicity. The mechanisms involved in benzene-induced nephrotoxicity are not fully understood.

    NEPHRO PROTECTIVE EFFECT OF VITELLARIA PARADOXA LEAVES ON BENZENE-INDUCED WISTAR RATS · 2026 · DOI

  • Notably, the observed upward trends in BNP and HIF–1α levels provide novel insights, as the roles of these molecules in cisplatin-induced neurotoxicity have not been previously investigated.

    Dose-dependent Cisplatin-induced neurotoxicity: Histopathological and molecular alterations in rat brain · 2026 · DOI

  • Background and purposeAnthracyclines, such as doxorubicin (DOX), are associated with late-onset kidney dysfunction; however, the mechanisms underlying chronic tubular injury remain poorly understood.

    Activation of the NAD⁺-Sirtuin Axis Protects Against Chronic Doxorubicin-Induced Subclinical Renal Tubular Injury Through Restoration of Mitochondrial Homeostasis and Suppression of Inflammation · 2026 · DOI

  • The study highlights the need to investigate the impact of vitamin C on antioxidant capacity and protein synthesis in the context of sodium fluoride exposure.

    Differential responses of neural-stem and kidney cells to sodium fluoride: insights into protein production, oxidative stress, and extracellular vesicle dynamics · 2026 · DOI

  • Further investigations are required to clinically prove its therapeutic effect. Future studies incorporating pharmacological inhibition would be valuable in providing mechanistic depth. Further studies are needed to evaluate the possible impact of SAR on the pharmacological actions of CYC.

    Saroglitazar Mitigated Cyclophosphamide-Induced Testicular Injury: Crosstalk Between Oxidative Stress, Inflammation and Apoptosis · 2026 · DOI

  • As a core mitochondrial quality control mechanism, mitophagy is closely related to the above pathological processes, but its overall regulatory network in Cis-AKI remains to be systematically clarified.

    Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets · 2026 · DOI

  • One challenge is the significant adverse effects of cisplatin, including cardiotoxicity. Another challenge is the unknown prevalence of cisplatin-induced cardiotoxicity. A technical challenge is the measurement of biomarkers and oxidative stress markers in rat cardiac tissue.

    Protective effects of avenanthramide-C against cisplatin-induced cardiotoxicity in rats by attenuating oxidative stress, inflammatory cytokines, and modulating p62–Keap1–Nrf2 pathway · 2025 · DOI

  • While the potential for cisplatin to cause chronic kidney disease (CKD) following repeated administration has been underexplored, effective therapeutic strategies for cisplatin-induced CKD are lacking.

    Indole-3-propionic acid exacerbates cisplatin-induced chronic kidney disease through the AHR/NF-κB signaling pathway · 2025 · DOI

  • It is well known that the stacking of thylakoids and the lateral macro-organization of the pigment–protein complexes in the membrane are interrelated (reviewed by Musta´rdy and Garab 2003; Dekker and Boekema 2005) but dgd1 is poorly characterized in this respect.

    Protective effects of dexpanthenol against diatrizoate-induced contrast nephropathy via the SIRT1–p53–Bcl-2/Bax pathway in rats · 2026 · DOI

  • The current treatments for renal ischemia-reperfusion injury have limited efficacy. The timing of agomelatine administration is crucial for its renoprotective effects.

    Agomelatine reduces oxidative stress and apoptosis in renal ischemia reperfusion injury · 2026 · DOI

  • The study aims to explore the therapeutic relevance of the gut-kidney axis in CKD.

    Haikunshenxi capsule alleviates renal fibrosis in chronic kidney disease via modulation of indoxyl Sulfate–Aryl hydrocarbon receptor signaling · 2026 · DOI

  • Determining the effects of NaOCI and ZnOCI on cells at the molecular level. Performing co-cultures of HaCaT keratinocyte cell line and L929 fibroblast cell line.

    The Effect of Hypochlorous Obtained From Different Salts on Keratinocyte and Fibroblast Cells · 2026 · DOI

  • The study identifies a gap in the current understanding of the comparative effectiveness of micellar and liposomal CoQ10 in reducing proinflammatory cytokines.

    The Impact of Micellar Coenzyme Q10 and Liposomal Coenzyme Q10 on TNF-α and IL-1β in Cisplatin-Induced Nephrotoxicity in Rats · 2026 · DOI

  • Investigate the effects of NaF on other cell types, - Examine the long-term effects of NaF exposure on cellular health, - Study the potential therapeutic applications of vitamin C in reducing NaF-induced oxidative…

    Differential responses of neural-stem and kidney cells to sodium fluoride: insights into protein production, oxidative stress, and extracellular vesicle dynamics · 2026 · DOI

  • The unpredictability and potentially fatal outcome of cisplatin-induced hepatotoxicity - The lack of understanding of the exact mechanism of cisplatin-induced liver injury - The need to validate the protective effect of licorice against CP-induced liver…

    Licorice attenuates cisplatin-induced hepatotoxicity by alleviating endoplasmic reticulum stress and apoptosis · 2025 · DOI

Most-cited papers in Chemotherapy-induced organ toxicity mitigation

Most recent work

Find a gap in your own Chemotherapy-induced organ toxicity mitigation sub-topic

This page shows what the Chemotherapy-induced organ toxicity mitigation literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,304 open questions
Substance Abuse Treatment and Outcomes
1,956 open questions
Dementia and Cognitive Impairment Research
1,232 open questions
Ferroptosis and cancer prognosis
1,146 open questions
Liver Disease Diagnosis and Treatment
1,049 open questions
Smoking Behavior and Cessation
1,025 open questions
Physical Activity and Health
1,002 open questions
Attention Deficit Hyperactivity Disorder
982 open questions
Open questions raised by papers listed on this page include: (1) There is a need for effective prevention strategies to mitigate Cisplatin-induced AKI (“Secukinumab Mitigates Cisplatin-Induced Nephrotoxicity and Enhances Cisplatin…”, 2026); (2) Although SIRT1/PGC-1α signaling was implicated, downstream targets and alternative mechanisms, including inflammatory signaling, mitophagy, ferroptosis, and NAD+ metabolism, remain to be investigated (“Sophocarpine Alleviates Renal Ischemia–Reperfusion Injury by Mitigating…”, 2026); (3) The underlying mechanisms of gut microbiota metabolites against renal fibrosis remain unclear (“Unveiling the therapeutic potential of gut microbiota metabolites for the…”, 2026); (4) Pyraclostrobin (PY) is a commonly applied strobilurin‐class fungicide that is frequently identified as a residue in food products, yet its nephrotoxic mechanisms remain unclear (“Pyraclostrobin Exposure Triggers Renal Injury by Activating Wnt/β‐Catenin…”, 2026); (5) There is a lack of studies on the nephroprotective effects of natural products (“Nephroprotective effect of seed extract and fractions of Telfairia occidentalis…”, 2026). 80 gap statements have been mined from Chemotherapy-induced organ toxicity mitigation papers in our 4.5M-paper local library, which holds 473 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.